Actively Recruiting
Hypnosis for Anxiety Relief in Adults with Hematologic Cancer Focusing on Patients with Diffuse Large B-Cell or Follicular Lymphoma Starting Hypnotherapy Within 2 Months of Diagnosis
Led by Hospices Civils de Lyon · Updated on 2025-09-11
50
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of hypnosis as a method to help patients manage anxiety related to hematologic cancers, specifically diffuse large cell B-cell lymphoma or follicular lymphoma. Hypnosis is a technique that focuses mental attention to reduce negative feelings or distress, and while it has shown benefits in breast cancer patients, its effect on anxiety in hematology patients has not been thoroughly studied. Participants will undergo hypnotherapy sessions, with anxiety measured before the first session, just before the third session, and after the third session via telephone consultation. The study observes the evolution of anxiety over time, including assessments at 6 weeks and 3 months after starting hypnotherapy. During the study, patients will complete anxiety questionnaires and attend hypnotherapy sessions as scheduled. Researchers will track changes in anxiety scores using the Hospital Anxiety and Depression Scale HADS. The main outcome is the anxiety level at 6 weeks after two hypnosis sessions, with additional follow-ups at 3 months to observe longer-term effects. The trial duration and participation involve these scheduled assessments and therapy sessions.
CONDITIONS
Brief Title
Hypnosis: a Path to Appeasement
Research Team
T
Thomas BERT
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here